J Cardiovasc Magn Reson. 2026 Sep 11:102798. doi: 10.1016/j.jocmr.2026.102798. Online ahead of print.ABSTRACTBACKGROUND: The left atrium is an early sensor of left ventricular (LV) dysfunction. The prognostic value of left atrial (LA) strain derived from CMR Feature-Tracking has been demonstrated in
Eur J Radiol. 2026 Sep 6;205:113219. doi: 10.1016/j.ejrad.2026.113219. Online ahead of print.ABSTRACTBACKGROUND: Because the causes of left ventricular hypertrophy (LVH) share a thickened-wall phenotype yet demand divergent management, from transthyretin stabilization in cardiac amyloidosis (CA) to
Front Cardiovasc Med. 2026 Aug 27;13:1787664. doi: 10.3389/fcvm.2026.1787664. eCollection 2026.ABSTRACTHypertrophic cardiomyopathy (HCM) is a common and highly heterogeneous inherited cardiomyopathy characterized by complex clinical phenotypes and diverse disease trajectories, posing significant cha
J Transl Med. 2026 Jul 25;24(1):1170. doi: 10.1186/s12967-026-08670-5.ABSTRACTBACKGROUND: Pathological cardiac hypertrophy serves as a key pathological precursor to heart failure (HF) and represents a major public health challenge worldwide. Although its clinical importance is well recognized, the u
No abstractJ Card Fail. 2026 Sep 10:S1071-9164(26)00529-4. doi: 10.1016/j.cardfail.2026.08.025. Online ahead of print.NO ABSTRACTPMID:42722326 | DOI:10.1016/j.cardfail.2026.08.025
Eur Heart J Digit Health. 2026 Sep 9;7(8):ztag140. doi: 10.1093/ehjdh/ztag140. eCollection 2026 Oct.ABSTRACTAIMS: Hypertrophic cardiomyopathy (HCM) remains underdiagnosed due to limited access to expert imaging. We developed and validated a deep-learning (DL)-based echocardiographic model adaptable
Intern Med. 2026 Sep 8. doi: 10.2169/internalmedicine.8114-26. Online ahead of print.ABSTRACTAlcohol septal ablation (ASA) is an established septal reduction therapy for patients with drug-refractory hypertrophic obstructive cardiomyopathy (HOCM). However, its impact on the long-term incidence of at
Heart Fail Clin. 2026 Oct;22(4):451-462. doi: 10.1016/j.hfc.2026.07.005. Epub 2026 Jul 30.ABSTRACTCardiac and neurologic manifestations are common in Fabry disease (FD) and significantly impact prognosis and quality of life. Cardiac involvement includes hypertrophic cardiomyopathy, arrhythmias, and
Open Heart. 2026 Sep 9;13(2):e004215. doi: 10.1136/openhrt-2026-004215.ABSTRACTBACKGROUND: Hypertrophic cardiomyopathy (HCM) exhibits complex phenotypic heterogeneity. Left ventricular myocardial strain and atrioventricular coupling hold significant clinical value in cardiovascular diseases; however
Clin Radiol. 2026 Jun 18;102:107416. doi: 10.1016/j.crad.2026.107416. Online ahead of print.ABSTRACTAIM: Recent advancements have introduced cardiac myosin inhibitors (CMIs) that have demonstrated significant efficacy in obstructive hypertrophic cardiomyopathy (oHCM). This meta-analysis aims to synt
PLoS One. 2026 Sep 9;21(9):e0342635. doi: 10.1371/journal.pone.0342635. eCollection 2026.ABSTRACTHypertrophic cardiomyopathy (HCM) is a genetic heart disease characterized by left ventricular hypertrophy. Mutations in genes for sarcomere proteins, e.g., in cardiac myosin-binding protein C (cMyBPC),
J Am Coll Cardiol. 2026 Aug 27:S0735-1097(26)07438-3. doi: 10.1016/j.jacc.2026.08.014. Online ahead of print.ABSTRACTBACKGROUND: Atrial fibrillation (AF) is pervasive and an independent driver of stroke and death in hypertrophic cardiomyopathy (HCM). Despite guideline recommendations for AF surveill
No abstractJ Am Coll Cardiol. 2026 Aug 27:S0735-1097(26)07365-1. doi: 10.1016/j.jacc.2026.07.042. Online ahead of print.NO ABSTRACTPMID:42714358 | DOI:10.1016/j.jacc.2026.07.042
Multimed Man Cardiothorac Surg. 2026 Sep 8;2026. doi: 10.1510/mmcts.2026.055.ABSTRACTHypertrophic obstructive cardiomyopathy is characterized by asymmetric septal hypertrophy and dynamic left ventricular outflow tract obstruction, often associated with systolic anterior motion of the mitral valve. I
J Physiol. 2026 Sep 9. doi: 10.1113/JP291248. Online ahead of print.ABSTRACTHypertrophic cardiomyopathy (HCM) caused by heterozygous pathogenic gene variants is characterized by highly variable disease phenotypes. Ageing and systemic metabolic disruption are thought to act as additional 'second hits
Diabetes Obes Metab. 2026 Sep 8. doi: 10.1111/dom.71324. Online ahead of print.ABSTRACTBACKGROUND AND AIM: Fabry disease (FD) is frequently complicated by renal impairment and cardiovascular events; however, evidence on sodium-glucose cotransporter-2 inhibitors (SGLT2i) in this population is scarce.
J Imaging Inform Med. 2026 Sep 8. doi: 10.1007/s10278-026-02248-9. Online ahead of print.ABSTRACTDifferentiating hypertrophic cardiomyopathy (HCM) from hypertensive heart disease (HHD) on cardiac magnetic resonance (CMR) native T1 mapping is clinically important, yet the two conditions overlap morph
J Imaging Inform Med. 2026 Sep 8. doi: 10.1007/s10278-026-02223-4. Online ahead of print.ABSTRACTMyocardial wall thickness is a key measurement in cardiac imaging: it guides the diagnosis of hypertrophic cardiomyopathy, informs risk stratification for sudden cardiac death, and tracks ventricular rem
No abstractJ Cardiovasc Med (Hagerstown). 2026 Aug 1;27(8):672-673. doi: 10.2459/JCM.0000000000001923. Epub 2026 Sep 1.NO ABSTRACTPMID:42710018 | DOI:10.2459/JCM.0000000000001923
No abstractFront Cardiovasc Med. 2026 Aug 24;13:1962442. doi: 10.3389/fcvm.2026.1962442. eCollection 2026.NO ABSTRACTPMID:42707263 | PMC:PMC13547494 | DOI:10.3389/fcvm.2026.1962442
Pacing Clin Electrophysiol. 2026 Sep 6. doi: 10.1111/pace.70420. Online ahead of print.ABSTRACTINTRODUCTION: Patient characteristics and predictors of early (ERAT) and late (LRAT) recurrence of atrial tachyarrhythmia by atrial fibrillation (AF) type after cryoballoon ablation (CBA) remain poorly def
Quant Imaging Med Surg. 2026 Sep 1;16(9):725. doi: 10.21037/qims-2026-1-0350. Epub 2026 Aug 5.ABSTRACTBACKGROUND: Differentiating cardiac amyloidosis (CA) from hypertrophic cardiomyopathy (HCM) is clinically challenging due to overlapping phenotypes of left ventricular hypertrophy. This study aimed
Neurol Genet. 2026 Sep 1;12(5):e200432. doi: 10.1212/NXG.0000000000200432. eCollection 2026 Oct.ABSTRACTBACKGROUND AND OBJECTIVES: Enzyme replacement therapy has not only significantly improved motor outcome and survival in patients with classic infantile Pompe disease, but also revealed previously
Hum Mutat. 2026 Sep 3;2026:4229370. doi: 10.1155/humu/4229370. eCollection 2026.ABSTRACTThe TTN gene encodes a crucial structural protein within cardiac sarcomeres, and its variants may contribute to hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy; however, phenotype and genotype are di
